Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 12:17 PM ET

Pharmaceuticals

Company Overview of Aura Biosciences, Inc.

Company Overview

Aura Biosciences, Inc. develops therapies that target and destroy cancer cells. It focuses on developing therapies that pinpoint solid tumors and metastases without harming surrounding tissue, enabling targeted treatment across a range of cancers. The company’s portfolio includes AU-011, a product that comprises a viral-like particle (VLP) that binds selectively to cancer cells in the eye, and upon activation with an ophthalmic laser the small molecule selectively destroys the membrane of cancer cells, killing them without damaging the overlaying retina. The company was founded in 2007 and is based in Cambridge, Massachusetts.

85 Bolton Street

Cambridge, MA 02140

United States

Founded in 2007

Phone:

617-401-3360

Fax:

617-401-3762

Key Executives for Aura Biosciences, Inc.

Founder, Chief Executive Officer and Director
Executive Chairman
Chief Financial Officer
Age: 60
Chief Operating Officer
Age: 53
Vice President of Technical Operations
Compensation as of Fiscal Year 2015.

Aura Biosciences, Inc. Key Developments

Aura Biosciences, Inc. Presents at Boston Biotech East West CEO Conference, Jan-10-2016 08:30 AM

Aura Biosciences, Inc. Presents at Boston Biotech East West CEO Conference, Jan-10-2016 08:30 AM. Venue: Four Seasons Hotel, 757 Market St., San Francisco, CA 94103, United States. Speakers: Elisabet de los Pinos, Founder, Chief Executive Officer and Director.

Aura Biosciences, Inc. Presents at Boston Biotech NY/NJ CEO Conference, Nov-13-2014 02:00 PM

Aura Biosciences, Inc. Presents at Boston Biotech NY/NJ CEO Conference, Nov-13-2014 02:00 PM. Venue: Apella, 450 East 29th Street, New York, New York, United States. Speakers: Elisabet de los Pinos, Founder, Chief Executive Officer and Director.

Aura Biosciences, Inc. Presents at Boston CEO Conference, Jun-04-2014 01:45 PM

Aura Biosciences, Inc. Presents at Boston CEO Conference, Jun-04-2014 01:45 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: Elisabet de los Pinos, Founder, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
Dartmouth-Hitchcock Clinic United States
GlaxoSmithKline Consumer Healthcare, L.P. United States
Celeres Pharmaceuticals, Inc. United States
ImmusanT, Inc. United States
Nascime Limited United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
February 24, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aura Biosciences, Inc., please visit www.aurabiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.